Effects of cinacalcet on atherosclerotic and nonatherosclerotic cardiovascular events in patients receiving hemodialysis: the EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events (EVOLVE) trial.
about
Left Ventricular Hypertrophy in Chronic Kidney Disease Patients: From Pathophysiology to Treatment.Acute effects of cinacalcet on arterial stiffness and ventricular function in hemodialysis patients: A randomized double-blinded crossover study.Clinical and Practical Use of Calcimimetics in Dialysis Patients With Secondary Hyperparathyroidism.Lessons Learned from EVOLVE for Planning of Future Randomized Trials in Patients on DialysisArrhythmia and Sudden Death in Hemodialysis Patients: Protocol and Baseline Characteristics of the Monitoring in Dialysis StudyPTH-dependence of the effectiveness of cinacalcet in hemodialysis patients with secondary hyperparathyroidismIntegral pharmacological management of bone mineral disorders in chronic kidney disease (part II): from treatment of phosphate imbalance to control of PTH and prevention of progression of cardiovascular calcification.Integral pharmacological management of bone mineral disorders in chronic kidney disease (part I): from treatment of phosphate imbalance to control of PTH and prevention of progression of cardiovascular calcification.Coronary Revascularization in Patients with CKD Stage 5D: Pragmatic Considerations.Cardiovascular complications in chronic dialysis patients.Sudden Cardiac Death Among Hemodialysis Patients.Should Statins Be Banned from Dialysis?Apolipoprotein B/apolipoprotein A1 ratio and mortality among incident peritoneal dialysis patients.
P2860
Q26773120-A874DD38-B8C2-4617-B658-F542973E815FQ33760506-DE1651C8-B344-440E-B32E-185B1D652A65Q36432849-11EC8F32-3692-4A07-80FC-64043C910541Q36687041-0ED518D0-7A82-48F0-AA55-51F5E7B6EEEBQ36770929-D1D8AD0A-CEED-4724-A78C-407DDAB425A3Q36793098-9609D5C0-548A-46E2-AA6E-D2B4D079ECD0Q38828618-3A66F1B5-32C1-4E83-B9DE-7F1A06738C1EQ38828902-82F44549-92D7-44F8-B773-58A2F9EE12C5Q38834281-7EC7FC3A-8050-4D59-A0E8-C1F899A5C67BQ38956399-DB9793C1-3358-46ED-9440-E2CCE2978AD2Q39145628-2809303F-40EE-4FA8-8EE5-31A0B08689FEQ54855603-F60B8678-FF5E-4D76-9061-F6EFD1BFE898Q55002489-6A371FA9-DC1C-498C-BE89-1DBD01F3E0A1
P2860
Effects of cinacalcet on atherosclerotic and nonatherosclerotic cardiovascular events in patients receiving hemodialysis: the EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events (EVOLVE) trial.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Effects of cinacalcet on ather ...... ascular Events (EVOLVE) trial.
@ast
Effects of cinacalcet on ather ...... ascular Events (EVOLVE) trial.
@en
type
label
Effects of cinacalcet on ather ...... ascular Events (EVOLVE) trial.
@ast
Effects of cinacalcet on ather ...... ascular Events (EVOLVE) trial.
@en
prefLabel
Effects of cinacalcet on ather ...... ascular Events (EVOLVE) trial.
@ast
Effects of cinacalcet on ather ...... ascular Events (EVOLVE) trial.
@en
P2093
P2860
P356
P1476
Effects of cinacalcet on ather ...... ascular Events (EVOLVE) trial.
@en
P2093
Bastian Dehmel
Charles A Herzog
David C Wheeler
EValuation Of Cinacalcet HCl T ...... s (EVOLVE) Trial Investigators
Geoffrey A Block
Gerard M London
Glenn M Chertow
Jürgen Floege
Marie-Louise Trotman
Patrick S Parfrey
P2860
P304
P356
10.1161/JAHA.114.001363
P407
P577
2014-11-17T00:00:00Z